NEW YORK (GenomeWeb) – The UK government has approved the use of noninvasive prenatal testing for trisomies 21, 18, and 13 as part of an existing prenatal screening program.

The decision follows a recommendation by the UK National Screening Committee (NSC) in January to evaluate NIPT as a secondary screening test, offering it as an alternative to an invasive diagnostic test for women deemed to be at high risk following the current primary screening test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.